Table 2.
EPI Compound 1 | Chemical Class | Structure | Efflux Pump(s) | Antimicrobials 2,3 | Reference |
---|---|---|---|---|---|
15-copaenol | terpene | NorA | EtBr, ciprofloxacin | [184] | |
α-bisabolol | terpene | NorA, TetK | Norfloxacin, tetracycline | [269] | |
α-terpinene | terpene | TetK | EtBr, tetracycline | [270] | |
benzophenanthridine | alkaloid | NorA | EtBr, ciprofloxacin | [271] | |
boeravinone B | flavonoid | NorA | EtBr, ciprofloxacin | [190] | |
chalcone | flavonoid | MepA, NorA | EtBr, norfloxacin | [272] | |
baicalein | flavonoid | MsrA, NorA | erythromycin, ciprofloxacin | [273] | |
caffeic acid | polyphenol | MsrA, NorA | EtBr, erythromycin, norfloxacin | [274] | |
caffeoylquinic acids | polyphenol | NorA | EtBr, ciprofloxacin, norfloxacin | [275] | |
capsaicin | alkaloid | NorA | EtBr, ciprofloxacin | [276] | |
coumarin | polyphenol | NorA | EtBr, norfloxacin | [277] | |
curcumin | polyphenol | NorA | ciprofloxacin | [278] | |
dimethyl octanol | terpene | NorA | EtBr, norfloxacin | [279] | |
genistein | flavonoid | NorA | EtBr, ciprofloxacin | [280] | |
indirubin | alkaloid | NorA | ciprofloxacin | [281] | |
kaempferol rhamnoside | flavonoid | NorA | EtBr, ciprofloxacin | [282] | |
limonene | terpene | MepA | EtBr, ciprofloxacin | [283] | |
nerol | terpene | NorA | EtBr, norfloxacin | [279] | |
olympicin A | flavonoid | NorA | enoxacin | [284] | |
osthol | polyphenol | NorA | ciprofloxacin | [278] | |
phyllanthin | polyphenol | NorA | EtBr, norfloxacin | [285] | |
piperine | alkaloid | MdeA, NorA | EtBr, mupirocin, ciprofloxacin | [286,287] | |
tannic acid | polyphenol | NorA | EtBr, norfloxacin | [288] |
1 Listed EPIs potentiated the activity of antimicrobials against S. aureus strains overexpressing efflux pumps. 2 Antimicrobial compounds that are known pump substrates and were included in susceptibility and/or checkerboard assays. 3 EtBr: ethidium bromide.